1-3 of 3
Alonso Ricardo, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Eculizumab and C5 Levels in PNH Treatment: Molar Ratio of Eculizumab to C5 Level Effectively Predicts Ongoing Dosage Changes in a Cohort of 50 Patients Treated with Eculizumab

Darren J Newton, PhD, Claire E McKinley, BSc, Alonso Ricardo, PhD, Michelle D Hoarty, PhD, Louise Arnold, Kathryn Riley, Nicola Copeland, Talha Munir, Morag Griffin, Anita Hill, MBChB (Hons), PhD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3484.
https://doi.org/10.1182/blood.V130.Suppl_1.3484.3484
Published: 2017
Journal Articles

Preclinical Evaluation of RA101495, a Potent Cyclic Peptide Inhibitor of C5 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Alonso Ricardo, PhD, Michelle Arata, MS, Steven DeMarco, PhD, Ketki Dhamnaskar, MS, Robert Hammer, PhD, Masha Fridkis-Hareli, PhD, Vaishnavi Rajagopal, PhD, Kathleen Seyb, PhD, Guo-Qing Tang, PhD, Sylvia Tobe, PhD, Douglas Treco, PhD
Journal: Blood
Blood (2015) 126 (23): 939.
https://doi.org/10.1182/blood.V126.23.939.939
Published: 2015
Journal Articles

Development of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases

Alonso Ricardo, PhD, Michelle Arata, Steven J DeMarco, PhD, Ketki Dhamnaskar, Robert Hammer, PhD, Kristopher Josephson, PhD, Kathleen Seyb, PhD, Sylvia Tobe, PhD, Zhaolin Wang, PhD, Hong Zheng, PhD, Douglas Treco, PhD
Journal: Blood
Blood (2014) 124 (21): 2936.
https://doi.org/10.1182/blood.V124.21.2936.2936
Published: 2014